Works matching IS 17555914 AND DT 2015 AND VI 33 AND IP 1

Results: 5

Cilostazol Does not Improve Peripheral Arterial Disease-Linked Oxidative Stress.
Published in:
Cardiovascular Therapeutics, 2015, v. 33, n. 1, p. 15, doi. 10.1111/1755-5922.12100
By:
- Bernal‐Lopez, M. Rosa;
- Peña, Daniel;
- Gomez‐Martin, Pilar;
- Tinahones, Francisco J.;
- Gomez‐Huelgas, Ricardo
Publication type:
Article
Metformin and its Effects on Myocardial Dimension and Left ventricular hypertrophy in Normotensive patients with Coronary Heart Disease (The MET- REMODEL Study): Rationale and Design of the MET- REMODEL Study.
Published in:
Cardiovascular Therapeutics, 2015, v. 33, n. 1, p. 1, doi. 10.1111/1755-5922.12101
By:
- Mohan, Mohapradeep;
- McSwiggan, Stephen;
- Baig, Fatima;
- Rutherford, Lynn;
- Lang, Chim C.
Publication type:
Article
Negative Hemodynamic Effects of Pantoprazole at High Infusion Rates in Mice.
Published in:
Cardiovascular Therapeutics, 2015, v. 33, n. 1, p. 20, doi. 10.1111/1755-5922.12102
By:
- Unsöld, Bernhard;
- Teucher, Nils;
- Didié, Michael;
- Sossalla, Samuel;
- Jacobshagen, Claudius;
- Seidler, Tim;
- Schillinger, Wolfgang;
- Hasenfuß, Gerd
Publication type:
Article
Resistant Hypertension and Renal Denervation Where to Now?
Published in:
Cardiovascular Therapeutics, 2015, v. 33, n. 1, p. 9, doi. 10.1111/1755-5922.12103
By:
- Shaw, James A.;
- Warren, Josephine L.
Publication type:
Article
Issue Information.
Published in:
Cardiovascular Therapeutics, 2015, v. 33, n. 1, p. i, doi. 10.1111/1755-5922.12104
Publication type:
Article